Get in Touch

Market opportunity awareness for oncology biomarker

  • Price Optimisation, Access Strategy
Working with P4A really helped us understanding where the product value sits and aligning our forecasting and in turn reassure our investors.
Global Program Leader

Client Challenge

The client needed support in understanding opportunities for use and a price point.

The client intended to launch a biomarker in two oncology indications but needed a support to realise what market opportunities were available.

P4A Solution

P4A identified patient pathways in the targeted indications, highlighting potential opportunities for the biomarker to add most value.

We developed a TPP to test potential price points and validated our initial price and use hypothesis with leading HCPs and payer representatives.

The Successful Outcome​

The client had a clear understanding about potential opportunities and was able to plan this into forecasting models.

Ultimately it helped the client understand the more about target markets and prioritise their outreach and launch strategy.

Need more details?

Do you want to learn more about the successful outcome for this case study? Are you interested in P4A Services or just want to say Hi?

get in touch

Explore other case studies

Understand evidence requirements beyond clinical trial data for launching an orphan drug in Türkiye & the GCC

  • Access Strategy

Optimising the PRMA potential of an orphan oncology asset in EU4 + UK and Japan

  • Access Strategy, Price Optimisation
p4a-logo-small-retina-white

We are award winning global experts in access for orphan drugs and Cell and Gene Therapies.

Twitter Instagram Youtube Linkedin

About

Services

Insights

Case Studies

Contact

  • Aramislaan 88,
  • 6213BV Maastricht, Netherlands
  • +31 6 55 88 71 96
  • contact@partners4access.com

P4A Services

For all access and Rare Disease related overview enquiries